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Although used as a model for examining the cardioactive effects of various compounds, the 
neuromuscular regulation of the heart of the crustacean Daphnia magna (D. magna) is not well 
understood. In the present study, we sought to determine how the heart rate of D. magna was 
affected  by  two  previously  untested  compounds:  curcumin  and  diphenhydramine  (DPHM). 
DPHM  produces  a  number  of  cardiotoxic  side  effects  in  vertebrates,  particularly  sinus 
tachycardia.  Curcumin  acts  as  a  monoamine  oxidase  inhibitor  (MAOI)  and  was  expected  to 
increase the heart rate of D. magna. DPHM was found unexpectedly to lower the heart rate of D. 
magna with time. Curcumin increased heart rate when administered in higher concentrations. 
However, co-administration of curcumin with DPHM negated this effect. These findings may be 
explained by the potential role of histamine as a sympathetic cardiac neurotransmitter in D. 
magna.  
 
Key words: curcumin; histamine; DPHM; heart rate; H1-histamine receptor; D. magna 
 
 
Introduction 
 
Daphnia  magna,  commonly  known  as 
water  fleas,  have  been  frequently  used  as  a 
model  organism  for  testing  cardioactive 
compounds.  These  planktonic  crustaceans  are 
translucent,  easily  maintained,  and  quickly 
affected  by  compounds  introduced  into  their 
surrounding  environment  (Campbell  et  al., 
2004).  Additionally,  D.  magna  and  humans 
show similar cardiac response to various drugs 
(Villegas-Navarro  et  al.,  2003;  Postmes  et  al., 
1989). Unlike higher order species of Crustacea, 
D. magna, have a myogenic heart with a cardiac 
pacemaker  similar  to  the  hearts  of  vertebrates 
(Spicer, 2001). This heart is composed of a thin 
layer  of  myocardial  cells,  making  it  easily 
modulated  by  small  concentrations  of 
cardioactive  compounds  (Stein  et  al.,  1966). 
Thus,  the  physiology  of  the  D.  magna  heart 
makes it a particularly useful model.  
Prior  studies  have  shown  that 
parasympathetic  regulation  of  the  D.  magna 
heart  is  similar  to  that  of  vertebrates. 
Acetylcholine had a negative chronotropic effect  
 
 
 
on D. magna, while atropine, an antagonist of 
the muscarinic M2 acetylcholine receptor, had a 
positive  effect  (Baylor,  1942;  Becker  and 
Krijgsman,  1951,  see  Villegas-Navarro  et  al., 
2003).  These  findings  match  studies  of  the 
pharmacology  of  the  vertebrate  heart 
(Blumenthal et al., 1968). However, sympathetic 
stimulation of the heart of D. magna appears to 
differ  from  the  myogenic  vertebrate  heart. 
Epinephrine  and  other  sympathomimetic  ß-
adrenergic  agonists  have  showed  both  weak 
positive  and  negative  chronotropic  effects 
(Villegas-Navarro  et  al.,  2003;  Postmes  et  al., 
1989).  Additionally,  several  ß-adrenergic 
antagonists  have  been  shown  both  to  increase 
and  decrease  the  heart  rate  of  D.  magna  in 
different studies (Villegas-Navarro et al., 2003; 
Dzialowski et al., 2005). It is possible that these 
seemingly contradictory results may stem from 
differences in concentration and exposure time. 
However,  this  ambiguity  indicates  possible 
differences  between  sympathetic  regulation  of 
D.  magna  and  vertebrate  hearts.  Thus,  it  is Page 2 of 12 
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necessary  first  to  clarify  the  neuromuscular 
interactions of the myogenic D. magna heart to 
establish  the  utility  of  this  animal  as  a  model 
organism. 
In  the  present  study,  the  cardioactive 
effects  of  diphenhydramine  (DPHM)  and 
curcumin (diferuloylmethane) in D. magna were 
tested. These drugs have not been tested in D. 
magna prior to this study. The effects of these 
drugs  on  the  heart  rate  of  D.  magna  were 
assessed to provide a better understanding of the 
sympathetic  and  parasympathetic  regulation  of 
the D. magna heart. 
DPHM  is  an  ethanolamine  derivative 
and  first  generation  H1-antihistamine.  It  is 
among  the  oldest  H1-antihistaminergic  drugs 
and  is  commonly  used  in  anti-allergy 
medications.  H1-histamine  receptors  are  G-
protein-coupled  receptors  that  activate  the 
phospholipase  C  and  the  phosphatidylinositol 
(PIP2) signaling pathways.  These receptors are 
found  in  smooth  muscles,  vascular  endothelial 
cells,  heart  tissues,  and  the  central  nervous 
system  in  vertebrates  (Reiner  and  Kamondi, 
1994; Mitsuchashi and Payan, 1989). Activation 
of H1 receptors on smooth muscle cells has been 
shown  to  generate  a  rise  of  intracellular  Ca
2+, 
which in turn enhanced Ca
2+ activated potassium 
channel  activity  and  served  to  hyperpolarize 
cells  (Ishikawa  et  al.,  1993).  As  an  inverse 
agonist  of  the  H1-histamine  receptor,  DPHM 
binds and stabilizes the inactive conformation of 
the  H1-histamine  receptor.  This  prevents  the 
transduction  of  the  H1-receptor  signaling 
pathway  and  diminishes  potassium  channel 
activity, resulting in a depolarizing effect (Leurs 
et al., 2002).  
First  generation  H1-antihistamines  are 
known to have a number of adverse side-effects, 
likely due to a relative lack of selectivity for the 
H1-receptor and other bioactive roles (Clark and 
Vance, 1992; Koppel et al., 1987).  In addition 
to relieving allergy symptoms, DPHM can act as 
a serotonin reuptake inhibitor (SSRI) and as a 
highly-potent  inhibitor  of  the  muscarinic  M2 
acetylcholine receptor (Simons, 2004; Liu et. al., 
2006),  potentially  leading  to  cardiac  toxicity 
(Fahy  et  al.  1989;  Kirk,  1998;  Richmond  and 
Seger,  1985).  DPHM  overdose  has  been 
associated  with  sinus  tachycardia,  ventricular 
tachycardia,  ventrical  arrhythmias,  torsades  de 
points,  cardiogenic  shock,  and  hypertension 
(Yap and Camm, 2002; de Abajo and Rodriguez, 
2000).  Additionally,  DPHM  and  other 
ethanolamine  derivatives  have  been  linked  to 
somnolence,  lethargy,  and  increases  in 
electroencephalographic abnormalities (Emadian 
et al., 1996; Litovitz et al., 2000). In rare cases, 
DPHM  overdose  has  produced  delirium  and 
psychosis (Jones et al., 1986; Serio, 2004). 
While  DPHM  produces  an  elevated 
heart  rate  in  humans  and  other  mammals,  its 
effects  in  crustaceans  have  not  been  studied. 
However, given that DPHM acts as a muscarinic 
M2  acetylcholine  receptor  antagonist,  it  was 
expected  to  have  an  atropine-like  negative 
chronotropic  effect  in  D.  magna  (Becker  and 
Krijgsman,  1951;  see  Villegas-Navarro  et  al., 
2003). Thus, the chronotropic effect of DPHM 
in  D.  magna  was  determined  to  compare  the 
cardiac  pharmacology  of  D.  magna  to 
mammalian models. 
Curcumin is a compound with a number 
of  bioactive  roles  and  a  rich  history.  Briefly, 
curcumin is the principle bioactive agent of the 
common spice known as turmeric. In addition to 
its culinary purposes, turmeric is frequently used 
in South Asian and Chinese holistic medicine as 
an anti-inflammatory agent (Goel et al., 2008). 
In addition to curcumin, turmeric contains two 
other structurally and pharmacologically similar 
curcuminoids:  curcumin  II  (demethoxycurcu-
min) and curcumin III (bisdemethoxycurcumin) 
in smaller quantities (Almeida et al., 2005; Naito 
et al., 2002).  
Curcumin  has  recently  gained  interest 
for  its  plethora  of  potential  medicinal  uses. 
Numerous  in  vivo  and  in  vitro  studies  have 
shown  that  curcumin  acts  as  an  anti-oxidant, 
anti-carcinogen,  anti-depressant,  and  iron 
chelator  (Weber  et  al.,  2005;  Kunnumakara  et 
al.,  2008;  Xu  et  al.,  2005;  Jiao  et  al.,  2006). 
Curcumin has no known toxic effects in humans 
or other animals and is safe in even high doses 
(Lao  et  al.,  2006).  Despite  these  findings, 
curcumin has an extremely low bioavailability. 
This is likely due to its hydrophobic character, 
as well as the glucuronidation and sulfation of 
curcumin  and  curcumin  metabolites  in  plasma 
(Anand et al., 2007). However, these metabolites 
maintain  some  of  curcumin’s  bioactive Page 3 of 12 
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properties  and  may  therefore  contribute  to  its 
potency (Naito et al., 2002). 
The  cardioactive  effects  of  curcumin 
have not been examined previously. Yet, there 
are a number of reasons to suspect that curcumin 
could  have  an  effect  on  the  heart  rate  of  D. 
magna. Curcumin is known to act as an inhibitor 
of MAOA and B  (Xu et al., 2005; Kulkarni et 
al., 2008). MAOIs have been found to increase 
heart rate (Dawson, 1995), though the cause of 
this  side-effect  is  not  well  understood. 
Combination of MAOIs and SSRIs can produce 
tachycardia,  believed  to  result  from  excessive 
serotonin (Boyer and Shannon, 2005). However, 
it is possible that the mechanism could be more 
direct.  Both  MAO-A  and  MAO-B  have  been 
identified  in  mammalian  cardiac  tissue 
(Rodriguez et al., 2001). Additionally, Crout et 
al. (1960) showed that administering MAOIs to 
rats could increase norepinephrine levels in heart 
tissue. While this would be expected to increase 
heart rate, the cardiac effects of MAOI-induced 
enhanced  norepinephrine  levels  have  not  been 
studied.  However,  norepinephrine  transport 
inhibitors  are  known  to  increase  heart  rate 
(Strempel  et  al.,  2008).  Thus,  blocking 
norepinephrine  degradation  would  very  likely 
have  a  positive  chronotropic  effect.  Curcumin 
could therefore increase heart rate by preventing 
the degradation of norepinephrine. 
Curcumin has been shown to localize to 
cardiac  tissue,  though  no  effects  on  heart  rate 
have been reported. Ryu et al. (2006) found that 
cardiac  curcumin  levels  in  mice  peaked  two 
minutes  after  curcumin  administration  and 
quickly decreased within 30 minutes. This short 
retention period could explain why curcumin has 
not been found to have a chronotropic effect in 
vertebrates. Yet it is very possible that an effect 
might  be  seen  in  the  more  ductile  heart  of  D. 
magna (Stein et al., 1966). 
The responses of D. magna to curcumin 
and DPHM were studied to elucidate differences 
and similarities in the pharmacology of the heart 
of D. magna and vertebrates. Unpurified, over 
the  counter  products  were  used  as  sources  for 
both  compounds.    Thus,  the  results  of  the 
present study were confounded by a number of 
potential  factors.  Compounds  were  tested  both 
alone  and  in  conjunction  with  different 
concentrations  of  curcumin.  DPHM  was 
expected to elevate the heart rate of D. magna 
by  directly  antagonizing  the  muscarinic  M2 
acetylcholine  receptor.  Curcumin  also  was 
expected to raise heart rate by increasing cardiac 
norepinephrine  levels.  Co-administration  of 
curcumin with DPHM was expected to increase 
the heart rate of D. magna further.  
 
 
Materials and Methods 
 
Animals 
D.  magna  were  ordered  from  Ward’s 
Natural  Science  (Rochester,  NY).    They  were 
stored  in  loosely  lidded  glass  jars  filled  with 
spring  water  and  kept  continuously  under  a 
portable  laboratory  lamp  issue  No.  G-998 
(Underwriters  Laboratories,  Camas,  WA)  to 
maintain a high rate of activity (Stearns, 1975).  
A new D. magna specimen was used for each 12 
minute experimental period. 
 
Diphenhydramine 
A  generic,  alcohol-free  liquid  allergy 
medication  for  children,  distributed  by  Target 
Corporation (Minneapolis, MN), was the source 
of  diphenhydramine  hydrochloride.  Other 
inactive  ingredients  listed  on  the  medication 
label  included  citric  acid,  red  food  coloring, 
flavor,  glycerin,  high  fructose  corn  syrup, 
poloxamer  307,  purified  water,  sodium 
benzoate,  sodium  chloride,  sodium  citrate  and 
sorbitol.  D. magna were observed in 4.28 mM 
diphenhydramine.    This  was  the  undiluted 
concentration found in the medication.      
 
Curcumin  
Curcumin  was  obtained  from 
commercial  gelatin  capsules  marketed  as 
Curcumin  95™  and  manufactured  by  Jarrow 
Formulas  (Los  Angeles,  CA).    Each  capsule 
contained  approximately  76%  curcumin,  18% 
curcumin II, 3% curcumin III and 3% cellulose. 
The inner contents of the capsules were added to 
water and filtered by gravity.  The curcumin was 
filtered  to  remove  large  particles.  A  precise 
concentration  of  curcumin  was  determined  by 
allowing the filtrate to evaporate and measuring 
the  mass  of  curcumin  remaining.    D.  magna Page 4 of 12 
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were observed in either a 3.62 µM or 7.24 µM 
concentration  of  curcumin.  The  filtrate  was 
protected  from  light  to  avoid  degrading  the 
curcumin. 
 
Measuring Heart Rate 
The  heart  rates  of  D.  magna  were 
observed  using  a  Nikon  C-DS  microscope. 
Individual  D.  magna  were  placed  on  concave 
microscope  slides  coated  with  petroleum  jelly 
(Best Yet; Oklahoma City, OK) and kept in 200 
µL of distilled water. Heart rate was measured 
twice in 2 minute intervals between 2-4 and 10-
12  minutes  after  administering  experimental 
compounds. D. magna in the control condition 
were kept in distilled water while experimental 
condition  D.  magna  were  administered 
appropriate  concentration  of  curcumin,  DPHM 
or both. 
 
Statistical Analysis 
The  standard  error  of  the  mean  was 
computed to determine the deviation of all data. 
Paired and unpaired two-tailed t-tests were used 
to determine the significance of the difference in 
heart  rate  between  treatments  and  times 
respectively.  A repeated measures ANOVA was 
used  to  determine  significant  interactions 
between  factors.    SPSS  15.0  and  Microsoft 
Excel  2007  were  used  to  conduct  statistical 
analyses.  
 
Illustrations  
  Adobe  Illustrator  CS3  was  used  to 
create figures for proposed mechanisms. 
 
 
Results 
 
The cardioactive effects of DPHM and 
curcumin  were  tested  in  D.  magna.  The  mean 
heart rates of D. magna in the different treatment 
conditions  between  2-4  minutes  and  10-12 
minutes are shown in Figure 1 and all values are 
reported in Table 1. The heart rate of untreated, 
control,  D.  magna  (n  =  30)  did  not  change 
significantly between the 2-4 and 10-12 minute 
intervals  (p  <  0.052)  based  on  student  t-tests.  
All  subject  values  (n)  refer  to  individual  D. 
magna used once for each test indicated.   The 
heart  rate  of  D.  magna  administered  3.62  µM 
curcumin (n = 6) did not change relative to the 
controls between 2-4 minutes (p < 0.736) or 10-
12  minutes  (p  <  0.557).  However,  D.  magna 
administered  7.24  µM  curcumin  (n  =  20) 
showed  a  significant  increase  in  heart  rate 
relative to the controls between 2-4 minutes (p < 
6.78  E-6),  and  remained  significantly  higher 
between 10-12 minutes (p < 2.13 E-5). 
The heart rate of D. magna administered 
4.28 mM DPHM (n = 31) was not significantly 
different from the controls between 2-4 minutes 
(p < 0.466). However, the heart rate of DPHM 
treated  D.  magna  was  significantly  lower  than 
the controls during the 10-12 minute interval (p 
< 0.0018).  
 
 
Table 1: Mean heart rate (bpm) of D. magna 
  2-4 Min.  10-12 Min. 
Control  215.6 ± 
4.8 
201.5 ± 5.4 
Curcumin (3.67 µM)  211.1 ± 
21.4 
192.75 ± 
19.5 
Curcumin (7.24 µM)  254.4 ± 
5.9  
247.7 ± 8.9 
DPHM  207.1 ± 
10.3 
192.7 ± 
19.5 
DPHM + Curcumin 
(3.67 µM) 
184.0 ± 
10.6 
122.9 ± 
10.9 
DPHM + Curcumin 
(7.24 µM) 
181.2 ± 
11.8 
111.9 ± 
10.3 
 
* 
*  * 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Co-administration  of  D.  magna  with 
3.67 µM curcumin and 4.28 mM diphenhydra-
mine (n = 33) slightly decreased the heart rate of 
D. magna at 2-4 minutes relative to the controls 
(p < 0.01) and greatly decreased the heart rate 
between 10-12 minutes relative to controls (p < 
4.57 E-8). Co-administration of D. magna with 
the 7.24 µM curcumin and 4.28 mM DPHM (n = 
20) did not result in a significant change in heart 
rate  between  2-4  minutes  relative  to  co-
administration  with  3.67  µM  curcumin  (p  < 
0.0036). Nor was a significant decrease seen in 
the  10-12  minute  internal  (p  <  6.58  E-11).  
Additionally,  student  t-tests  demonstrated  that 
there was no significant difference in heart rate 
between  2-4  minutes  and  10-12  minutes  when 
D. magna were administered 3.67 µM curcumin 
(p < 0.541) and 7.24 µM curcumin (p < 0.535).   
  An ANOVA revealed that DPHM had a 
significant  effect  on  heart  rate  (p  <  0.001).  A 
significant  interaction  was  also  seen  between 
time  and  DPHM  (p  <  0.001).  No  interaction 
between  time  and  curcumin  was  found  (p  < 
0.543).  Also, no significant effect was seen with 
curcumin  alone  (p  <  0.816)  or  with  curcumin 
and  DPHM  (p  <  0.374).    When  3.67  µM 
curcumin  was  not  included  in  the  ANOVA,  a 
reduction  in  p  value  for  curcumin  alone  (p  < 
0.518),  and  curcumin  and  DPHM  (p  <  0.167) 
was noted.  The interaction between curcumin, 
DPHM,  and  time  was  not  significant  with  the 
3.67 µM curcumin (p < 0.995) and without the 
3.67  µM  curcumin  (p  <  0.951),  though  a 
reduction in the p-value was seen.    
 
 
Discussion 
 
DPHM  had  a  time-dependent  negative 
chronotropic  effect  on  D.  magna,  while 
curcumin had a positive chronotropic effect that 
was  unchanged  with  time.  The  positive 
chronotropic  effect  of  curcumin  was  not  seen 
when  co-administered  with  DPHM.  ANOVA 
analysis  did  not  find  a  significant  interaction 
between curcumin and DPHM. This was likely 
due to the compounding of experimental error. 
Removing  the  lower  curcumin  concentration 
condition from the ANOVA improved the size 
of  the  effect  of  curcumin,  though  not  within 
significance.  However,  a  student’s  t-test 
suggested  that  significant  differences  existed 
between co-administration and single drug trials. 
These  results  significantly  differed  from  the 
Figure 1. Mean heart rate (bpm) with standard error in for D.magna administered distilled water (controls), 3.62 µM and 
7.24 µM dilutions of curcumin, 4.28 mM diphenhydramine (DPHM) and co-administered 4.28 mM DPHM and both 
curcumin concentrations. Heart rate taken between 2-4 minutes and 10-12 minutes after administration is shown.  (*) 
indicates  p < 0.05 compared to control within the same time interval. (**)  indicates p < 0.05 between time intervals. 
*  * 
*  * 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hypothesized  effects  and  indicate  that  the 
myogenic  heart  of  D.  magna  is  substantially 
different from the vertebrate heart. 
DPHM was expected to have a positive 
chronotropic effect, given that the drug is known 
to  induce  tachycardia  in  humans  and  other 
mammalian  animal  models  (Yap  and  Camm, 
2002; de Abajo and Rodriguez, 2000). It is not 
clear  why  the  reverse  effect  was  seen  in  D. 
magna.  It  is  possible  that  the  anticholinergic 
effects of DPHM were somehow reduced in D. 
magna  or  simply  not  present  with  the 
concentration  used.  This  is  particularly  worth 
noting  given  the  ample  evidence  that 
acetylcholine  and  acetylcholinergic  drugs 
produce similar results in D. magna as in other 
organisms with myogenic hearts (Baylor, 1942; 
Bekker and Krijgsman, 1951). It is also possible 
that the negative effects might not have been due 
to  DPHM  at  all.  The  generic  anti-allergy 
formula  used  in  this  study  contained  several 
inactive ingredients that could have confounded 
these results. 
The  positive  chronotropic  effect  of 
curcumin in D. magna confirmed expectations. 
This  effect  appeared  to  occur  within  the  0-4 
minute period after curcumin administration and 
was unchanged by 10-12 minutes. This indicated 
a  fast  acting,  positive  chronotropic  role  for 
curcumin that has not been previously reported. 
However,  co-administration  of  DPHM 
unexpectedly  negated  this  effect  between  2-4 
and 10-12 minutes. 
While curcumin increased heart rate as 
expected,  co-administeration  with  DPHM  was 
not expected to negate this effect. If the positive 
chronotropic effects of curcumin were mediated 
through  increased  norepinephrine  levels,  as 
hypothesized,  co-administration  of  DPHM 
would  not  have  shown  the  effect  found  here. 
While  curcumin  had  a  positive  chronotropic 
effect  within  two  minutes  of  administration, 
DPHM  did  not  have  an  effect  until  10  to  12 
minutes. Thus, if the positive chronotropic effect 
of  curcumin  was  due  to  increased  synaptic 
norepinephrine  levels,  co-administration  with 
DPHM would not be expected to influence this 
effect between 2-4 minutes. This suggests that 
the positive chronotropic effect of curcumin and 
the negative chronotropic effects of DPHM were 
mediated by a common mechanism. 
As  noted  previously,  several  studies 
have  suggested  that,  unlike  in  vertebrates, 
norepinephrine  is  not  the  primary  cardiac 
sympathetic  neurotransmitter  in  D.  magna 
(Villegas-Navarro  et  al.,  2003;  Postmes  et  al., 
1989;  Dzialowski  et  al.,  2005).  However,  no 
studies have shown evidence for an alternative 
mode  of  sympathetic  neurotransmission  in  D. 
magna. Based on the results of the current study, 
we  propose  that  histamine  may  act  as  a 
sympathetic  neurotransmitter  in  D.  magna  by 
binding  to  an  H1-histamine  receptor  type 
homologue. 
DPHM could have reduced heart rate by 
acting as an inverse agonist at the H1-histamine 
receptor. DPHM has only been shown to have a 
negative chronotropic effect in one other study 
in  isolated  rat  atria  (Pousti  et  al.,  2003). 
However, these results have not been supported 
by  other  studies  of  DPHM  in  rats  and  other 
mammalian  models  (Liu  et  al.,  2006;  Simons, 
2004).  Differences  between  the  interaction  of 
DPHM  and  the  muscarinic  M2  acetylcholine 
receptor  may  explain  the  observed  lack  of  a 
positive  chronotropic  effect  in  D.  magna. 
Figure 2. A proposed explanation for the cardioactive 
role of diphenhydramine (DPHM) in Daphnia magna. 
Histamine (HA) may be released by sympathetic cardiac 
neurons,  producing  a  positive  chronotropic  effect  by 
binding the H1-histamine receptor (H1-HA-R). DPHM 
is known to act as an inverse agonist at H1-HA-R. Thus, 
DPHM  may  prevent  the  sympathetic  actions  of  HA. 
Unlike  in  mammalian  models,  DPHM  may  not 
antagonize  the  muscarinic  acetylcholine  receptor  M2 
(ACh-R)  in  D.  magna.  Thus,  parasympathetic 
acetylcholine  (ACh)  may  freely  bind  the  ACh-R  on 
myocardial cells and reduce heart rate. Page 7 of 12 
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Additionally,  the  inverse  agonist  effect  of 
DPHM on the H1-histamine receptor may have 
produced  the  observed  negative  chronotropic 
effect. A proposed mechanism for the effects of 
DPHM on the heart of D. magna is shown in 
Figure 2.  
Serotonin  receptors  on  the  heart  have 
been  found  to  modulate  heart  rate  and  other 
cardiac  functions  in  rats  (Bagdy  et  al.,  1989). 
However,  the  negative  chronotropic  effects  of 
DPHM probably did not result from the drug’s 
activity as an SSRI. Curcumin has been found to 
increase serotonin levels as an MAOI potently 
(Xu  et  al.,  2005;  Kulkarni  et  al.,  2008). 
Therefore,  if  serotonin  had  a  negative 
chronotropic effect in D. magna, administration 
of curcumin would more likely have decreased 
heart rate, which was not the case. 
It  is  possible  that  curcumin  could 
prevent  the  degradation  of  histamine,  resulting 
in  increased  levels  of  sympathetic  histamine 
release.  Numerous  similar  MAOIs  inhibit 
histamine  N-methyltransferase  (HNMT),  an 
enzyme involved in the metabolism of histamine 
(Boudikovi-Girard  et  al.,  1993).  However,  the 
effects  of  curcumin  on  HNMT  have  not  been 
investigated.  A  possible  mechanism  for  the 
cardioactive effects of curcumin in D. magna is 
shown in Figure 3. 
Several  species  of  crustaceans  express 
high  levels  of  histamine  on  the  heart  and 
pericardial  tissue  (Fingerman  et  al.,  1981). 
However, the role of the neurotransmitter in the 
heart of D. magna and other crustaceans is not 
well  understood.  Additionally,  no  study  has 
examined the presence of histamine receptors in 
D.  magna  and  only  few  G-protein  coupled 
putative histamine receptors have been identified 
in  invertebrates  (Hamdan  et  al.,  2002). 
Administration  of  histamine  elevated  the  heart 
rate  of  the  scorpion  Palamnaeus  bengalensis, 
which has a similar myogenic physiology to D. 
magna  (Kanungo,  1957).  However,  histamine 
did  not  affect  the  myogenic  heart  of  the 
crustacean  species  Triops  longicaudatus 
(Yamagishi,  2003).  Thus,  previous  studies  do 
not indicate any clear role for histamine in the 
cardiac system of D. magna.  
Relatively little research has been done 
on  the  interaction  of  curcumin  and  histamine. 
However,  a  few  studies  have  reported  that 
curcumin antagonizes histamine responses in a 
variety of ways. Ram et al., (2003) found that 
curcumin  attenuated  allergic  respiratory 
responses  in  guinea  pigs.  Curcumin  has  also 
been shown to inhibit the release of histamine in 
vitro  through  its  antioxidative  mechanisms 
(Suzuki et al., 2005). Extract of Curcuma longa, 
the plant from which turmeric and curcumin are 
derived,  protected  rats  from  gastric  ulcers  by 
antagonizing  the  H2-histamine  receptor.  While 
curcumin  itself  did  not  bind  the  receptor,  it  is 
possible that another curcuminoid in the extract 
did (Kim et al., 2005).  
As  this  proposed    mechanism  for  the 
action  of  curcumin  is  tentative,  it  should  be 
noted  that  curcumin  could  potentially  increase 
the  heart  rate  of  D.  magna  through  other 
pathways.  In  addition,  this  mechanism  may 
appear  to  contradict  studies  of  the  anti-
inflammatory functions of curcumin (Ram et al., 
2003).  However,  Suzuki  et  al.  (2005)  showed 
that  the  anti-histaminergic  effects  of  curcumin 
were  largely  due  to  the  compound’s  anti-
oxidative  function.  Thus,  curcumin  could 
potentially  act  as  an  anti-inflammatory  agent, 
Figure  3.  A  proposed  mechanism  for  the  positive 
chronotropic  effect  of  curcumin  in  Daphnia  magna. 
Histamine  (HA)  produces  a  positive  chronotropic  effect 
(refer to Figure 2). HA is taken back up by  the vesicular 
monoamine  transporter-2  (VMAT-2)  and  either 
repackaged  into  synaptic  vesicles  or  methylated  by 
histamine N-methyl transferase (HNMT). Curcumin may 
antagonize  HNMT,  preventing  HA  methylation. 
Additionally,  curcuminoids  may  antagonize  the 
myocardial H2-histamine receptor (H2-HA-R). However, 
it  is  not  clear  how  binding  of  endogenous  HA  to  this 
receptor may affect the heart rate of D.magna.  Page 8 of 12 
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while  also  preventing  the  degradation  of 
histamine  in  D.  magna  under  non-oxidative 
stress conditions. Additionally, the inclusion of 
curcuminoids in the curcumin filtrate may have 
confounded  the  results  of  this  study.  These 
curcuminoids  could  have  antagonized  H2-
histamine receptors in D. magna, as suggested in 
Kim  et  al.  (2005).  It  is  possible  that 
curcuminoids  affected  the  transduction  of 
histamine  responses  in  myocardial  cells  in  a 
non-curcumin dependent way.  
It has been speculated that histamine has 
a  major  role  as  a  neurotransmitter  in  the 
sympathetic heart ganglia of vertebrates (Fryer, 
2006). There is evidence that histamine may be 
released  by  sympathetic  cardiac  neurons  and 
attenuate  the  release  of  norepinephrine  and 
histamine by binding the H3-histamine receptor 
on cardiac sympathetic neuron terminals (Li et 
al., 2006; Imamura et al., 1994). Other studies 
have  suggested  that  histamine  and 
norepinephrine  may  both  modulate  cardiac 
sympathetic  responses  through  joint  negative 
feedback mechanisms (Krzan, 1996).  
Histamine has been found to produce a 
positive  chronotropic  effect  when  directly 
administered to cardiac tissue in multiple animal 
models (Eckel et al., 1982). However, the effects 
of histamine appear to be modulated by different 
receptors  in  different  animals.  H2-histamine 
receptor  agonists  increased  the  heart  rate  of 
guinea pigs, though H1 receptor agonists had no 
effect (Flynn et al., 1979). However, Salata et al. 
(1995)  found  that  the  H1  receptor  antagonist 
astemizole  produced  a  negative  chronotropic 
effect  in  anesthetized  dogs.  Additionally, 
Genovesse  et  al.  (1988)  found  that  the  H1-
histamine  receptor  mediated  negative 
chronotropic  and  inotropic  effects  in  human 
atrial myocardial cells. Thus, the functions of the 
H1 and H2-histamine receptors appear to differ 
between animal models. 
The expression patterns of receptors in 
cardiac  tissue  also  differ  between  animal 
models.  (Flynn  et  al.,  1979;  Genovesse  et  al., 
1988; Salta et al., 1995). Several mammals have 
been  found  to  express  very  different 
distributions of H1 and H2 receptors on cardiac 
tissue  (Matsuda  et  al.,  2004).  Little  is  known 
about the cardiac histamine receptor profile of 
myogenic crustaceans like D. magna. However, 
differences between mammals imply limitations 
in applying data across models. Further study of 
the localization of cardiac histamine receptors in 
crustaceans is necessary to resolve this issue.  
The  results  of  this  study  demonstrated 
that  the  H1-antihistamine  DPHM  exhibited  an 
unexpected negative chronotropic effect on the 
heart rate of D. magna. Additionally, curcumin, 
a  possible  HNMT  antagonist,  produced  a 
positive  chronotropic  effect.  This  effect  was 
negated by DPHM. Based on these results, we 
propose that histamine may act as the primary 
cardiac  sympathetic  neurotransmitter  in  D. 
magna,  possibly  in  lieu  of  norpeinephrine. 
However,  the  mechanisms  described  here  are 
highly speculative. Future studies should seek to 
determine whether histamine changes the heart 
rate  of  D.  magna,  whether  curcumin  inhibits 
HNMT and how the interaction of DPHM and 
the muscarinic M2 acetylcholine receptor differs 
in  D.  magna.  Better  understanding  of 
metabotropic  histamine  receptors  in  D.  magna 
and crustaceans is also necessary. These studies 
should also test the effects of pure curcumin and 
DPHM to limit further sources of experimental 
error. 
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